These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 11737051

  • 1. Differential effect of phosphodiesterase inhibitors on IL-13 release from peripheral blood mononuclear cells.
    Yoshida N, Shimizu Y, Kitaichi K, Hiramatsu K, Takeuchi M, Ito Y, Kume H, Yamaki K, Suzuki R, Shibata E, Hasegawa T, Takagi K.
    Clin Exp Immunol; 2001 Dec; 126(3):384-9. PubMed ID: 11737051
    [Abstract] [Full Text] [Related]

  • 2. Cyclic AMP-elevating agents inhibit mite-antigen-induced IL-4 and IL-13 release from basophil-enriched leukocyte preparation.
    Shichijo M, Shimizu Y, Hiramatsu K, Inagaki N, Tagaki K, Nagai H.
    Int Arch Allergy Immunol; 1997 Dec; 114(4):348-53. PubMed ID: 9414138
    [Abstract] [Full Text] [Related]

  • 3. Selective type IV phosphodiesterase inhibitors prevent IL-4-induced IgE production by human peripheral blood mononuclear cells.
    Coqueret O, Boichot E, Lagente V.
    Clin Exp Allergy; 1997 Jul; 27(7):816-23. PubMed ID: 9249275
    [Abstract] [Full Text] [Related]

  • 4. Possible Contribution of Prostaglandin E2 to the antiproliferative effect of phosphodiesterase 4 inhibitors in human mononuclear cells.
    Banner KH, Hoult JR, Taylor MN, Landells LJ, Page CP.
    Biochem Pharmacol; 1999 Nov 01; 58(9):1487-95. PubMed ID: 10513992
    [Abstract] [Full Text] [Related]

  • 5. Phosphodiesterase and cyclic adenosine monophosphate-dependent inhibition of T-lymphocyte chemotaxis.
    Hidi R, Timmermans S, Liu E, Schudt C, Dent G, Holgate ST, Djukanović R.
    Eur Respir J; 2000 Feb 01; 15(2):342-9. PubMed ID: 10706503
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids.
    Sinha B, Semmler J, Eisenhut T, Eigler A, Endres S.
    Eur J Immunol; 1995 Jan 01; 25(1):147-53. PubMed ID: 7843225
    [Abstract] [Full Text] [Related]

  • 9. Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD.
    Jones NA, Leport M, Holand T, Vos T, Morgan M, Fink M, Pruniaux MP, Berthelier C, O'Connor BJ, Bertrand C, Page CP.
    Pulm Pharmacol Ther; 2007 Jan 01; 20(1):60-8. PubMed ID: 16427796
    [Abstract] [Full Text] [Related]

  • 10. Modulation of Th1- and Th2-like cytokine production from mitogen-stimulated human peripheral blood mononuclear cells by phosphodiesterase inhibitors.
    Yoshimura T, Nagao T, Nakao T, Watanabe S, Usami E, Kobayashi J, Yamazaki F, Tanaka H, Inagaki N, Nagai H.
    Gen Pharmacol; 1998 Feb 01; 30(2):175-80. PubMed ID: 9502171
    [Abstract] [Full Text] [Related]

  • 11. Preliminary identification and role of phosphodiesterase isozymes in human basophils.
    Peachell PT, Undem BJ, Schleimer RP, MacGlashan DW, Lichtenstein LM, Cieslinski LB, Torphy TJ.
    J Immunol; 1992 Apr 15; 148(8):2503-10. PubMed ID: 1373172
    [Abstract] [Full Text] [Related]

  • 12. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function.
    Weston MC, Anderson N, Peachell PT.
    Br J Pharmacol; 1997 May 15; 121(2):287-95. PubMed ID: 9154339
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interleukin-5 production by peripheral blood mononuclear cells of asthmatic patients is suppressed by T-440: relation to phosphodiesterase inhibition.
    Kaminuma O, Mori A, Suko M, Kikkawa H, Ikezawa K, Okudaira H.
    J Pharmacol Exp Ther; 1996 Oct 15; 279(1):240-6. PubMed ID: 8858999
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways.
    Moon EY, Lee GH, Lee MS, Kim HM, Lee JW.
    Life Sci; 2012 Feb 27; 90(9-10):373-80. PubMed ID: 22227470
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differential effect of phosphodiesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis.
    Banner KH, Roberts NM, Page CP.
    Br J Pharmacol; 1995 Dec 27; 116(8):3169-74. PubMed ID: 8719792
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.